Vivos Therapeutics Inc (NAS:VVOS)
$ 2.1 -0.07 (-3.23%) Market Cap: 6.78 Mil Enterprise Value: 6.27 Mil PE Ratio: 0 PB Ratio: 10.00 GF Score: 59/100

Q4 2021 Vivos Therapeutics Inc Earnings Call Transcript

Mar 31, 2022 / 09:00PM GMT
Release Date Price: $67 (+1.13%)
Operator

Please stand by. We're about to begin. Good day, everyone, and welcome to the Vivos Therapeutics fourth-quarter and full-year 2021 earnings conference call. (Operator Instructions) This conference call is being recorded, and a replay of today's call will be available on the Investor Relations section of Vivos' website and will remain posted there for the next 30 days.

I'll now hand the call over to Julie Gannon, Vivos' Investor Relations Officer for introductions and the reading of the Safe Harbor statement. Please go ahead.

Julie Gannon
Vivos Therapeutics, Inc. - Chief of Staff & IR

Thank you, operator. Hello, everyone, and welcome to the Vivos Therapeutics fourth-quarter and full-year 2021 earnings conference call. A copy of our earnings press release is available on the Investor Relations section of our website at www.vivos.com.

With us on today's call are Kirk Huntsman, Vivos' Chairman and Chief Executive Officer; and Brad Amman, Chief Financial Officer. Today, we'll

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot